Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
 
Sponsors and Collaborators
Amgen
Daiichi Sankyo Inc.
 
Contact
Amgen Call Center
866-572-6436
 
ClinicalTrials.gov Identifier